rs17178299

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001481.3(DRC4):​c.776G>A​(p.Arg259Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0571 in 1,611,484 control chromosomes in the GnomAD database, including 3,097 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R259W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.046 ( 216 hom., cov: 33)
Exomes 𝑓: 0.058 ( 2881 hom. )

Consequence

DRC4
NM_001481.3 missense

Scores

6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.70

Publications

28 publications found
Variant links:
Genes affected
DRC4 (HGNC:4166): (growth arrest specific 8) This gene includes 11 exons spanning 25 kb and maps to a region of chromosome 16 that is sometimes deleted in breast and prostrate cancer. The second intron contains an apparently intronless gene, C16orf3, that is transcribed in the opposite orientation. This gene is a putative tumor suppressor gene. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
DRC4 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 33
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015008748).
BP6
Variant 16-90037251-G-A is Benign according to our data. Variant chr16-90037251-G-A is described in ClinVar as Benign. ClinVar VariationId is 402892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.118 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC4NM_001481.3 linkc.776G>A p.Arg259Gln missense_variant Exon 7 of 11 ENST00000268699.9 NP_001472.1 O95995-1A0A384MR00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAS8ENST00000268699.9 linkc.776G>A p.Arg259Gln missense_variant Exon 7 of 11 1 NM_001481.3 ENSP00000268699.4 O95995-1

Frequencies

GnomAD3 genomes
AF:
0.0458
AC:
6962
AN:
152128
Hom.:
215
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0109
Gnomad AMI
AF:
0.0505
Gnomad AMR
AF:
0.0253
Gnomad ASJ
AF:
0.0507
Gnomad EAS
AF:
0.126
Gnomad SAS
AF:
0.0272
Gnomad FIN
AF:
0.0757
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0622
Gnomad OTH
AF:
0.0358
GnomAD2 exomes
AF:
0.0523
AC:
12981
AN:
248434
AF XY:
0.0511
show subpopulations
Gnomad AFR exome
AF:
0.00975
Gnomad AMR exome
AF:
0.0370
Gnomad ASJ exome
AF:
0.0479
Gnomad EAS exome
AF:
0.121
Gnomad FIN exome
AF:
0.0777
Gnomad NFE exome
AF:
0.0566
Gnomad OTH exome
AF:
0.0470
GnomAD4 exome
AF:
0.0582
AC:
84987
AN:
1459238
Hom.:
2881
Cov.:
31
AF XY:
0.0571
AC XY:
41409
AN XY:
725666
show subpopulations
African (AFR)
AF:
0.00757
AC:
253
AN:
33406
American (AMR)
AF:
0.0337
AC:
1499
AN:
44426
Ashkenazi Jewish (ASJ)
AF:
0.0477
AC:
1241
AN:
26028
East Asian (EAS)
AF:
0.0726
AC:
2875
AN:
39618
South Asian (SAS)
AF:
0.0206
AC:
1768
AN:
85902
European-Finnish (FIN)
AF:
0.0770
AC:
4108
AN:
53356
Middle Eastern (MID)
AF:
0.0105
AC:
57
AN:
5440
European-Non Finnish (NFE)
AF:
0.0626
AC:
69575
AN:
1110822
Other (OTH)
AF:
0.0599
AC:
3611
AN:
60240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
4197
8393
12590
16786
20983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2596
5192
7788
10384
12980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0457
AC:
6960
AN:
152246
Hom.:
216
Cov.:
33
AF XY:
0.0458
AC XY:
3408
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0109
AC:
452
AN:
41570
American (AMR)
AF:
0.0252
AC:
386
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0507
AC:
176
AN:
3470
East Asian (EAS)
AF:
0.126
AC:
652
AN:
5176
South Asian (SAS)
AF:
0.0274
AC:
132
AN:
4814
European-Finnish (FIN)
AF:
0.0757
AC:
803
AN:
10608
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0622
AC:
4232
AN:
67994
Other (OTH)
AF:
0.0364
AC:
77
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
332
663
995
1326
1658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0530
Hom.:
795
Bravo
AF:
0.0405
TwinsUK
AF:
0.0704
AC:
261
ALSPAC
AF:
0.0625
AC:
241
ESP6500AA
AF:
0.0114
AC:
50
ESP6500EA
AF:
0.0600
AC:
516
ExAC
AF:
0.0498
AC:
6042
Asia WGS
AF:
0.0760
AC:
262
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Primary ciliary dyskinesia 33 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.54
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.037
.;T;T
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Benign
0.68
D
LIST_S2
Uncertain
0.90
D;D;D
MetaRNN
Benign
0.0015
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
5.7
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-2.1
N;N;.
REVEL
Benign
0.13
Sift
Uncertain
0.0090
D;D;.
Sift4G
Uncertain
0.015
D;D;D
Polyphen
0.77
.;P;.
Vest4
0.055
MPC
0.022
ClinPred
0.024
T
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.10
gMVP
0.22
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17178299; hg19: chr16-90103659; COSMIC: COSV51946631; COSMIC: COSV51946631; API